Epidemiology and risk factors for chronic kidney disease

被引:53
作者
McClellan, WM [1 ]
机构
[1] Emory Univ, Rollins Sch Publ Hlth, Dept Epidemiol, Atlanta, GA 30322 USA
[2] Georgia Med Care Fdn, Hlth Serv Res, Atlanta, GA 30329 USA
关键词
D O I
10.1016/j.mcna.2004.11.006
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Groups at high risk for increased prevalence of chronic kidney disease (CKD) include individuals with a family history of end-stage renal disease, diabetes, hypertension, and cardiovascular disease. Therapeutic interventions that delay or prevent progressive kidney disease are well established and incorporated into widely disseminated clinical practice guidelines. These interventions also reduce the risk of cardiovascular disease and should be regarded as essential components of care of CKD. Achieving high levels of medically appropriate care of CKD patients and reduction in risk of progression to end-stage renal disease may be delayed by barriers created by individual and regional poverty.
引用
收藏
页码:419 / +
页数:28
相关论文
共 168 条
[1]   VETERANS AFFAIRS COOPERATIVE STUDY ON GLYCEMIC CONTROL AND COMPLICATIONS IN TYPE-II DIABETES (VA CSDM) - RESULTS OF THE FEASIBILITY TRIAL [J].
ABRAIRA, C ;
COLWELL, JA ;
NUTTALL, FQ ;
SAWIN, CT ;
NAGEL, NJ ;
COMSTOCK, JP ;
EMANUELE, NV ;
LEVIN, SR ;
HENDERSON, W ;
LEE, HS .
DIABETES CARE, 1995, 18 (08) :1113-1123
[2]   Effect of ramipril vs amlodipine on renal outcomes in hypertensive nephrosclerosis - A randomized controlled trial [J].
Agodoa, LY ;
Appel, L ;
Bakris, GL ;
Beck, G ;
Bourgoignie, J ;
Briggs, JP ;
Charleston, J ;
Cheek, D ;
Cleveland, W ;
Douglas, JG ;
Douglas, M ;
Dowie, D ;
Faulkner, M ;
Gabriel, A ;
Gassman, J ;
Greene, T ;
Hall, Y ;
Hebert, L ;
Hiremath, L ;
Jamerson, K ;
Johnson, CJ ;
Kopple, J ;
Kusek, J ;
Lash, J ;
Lea, J ;
Lewis, JB ;
Lipkowitz, M ;
Massry, S ;
Middleton, J ;
Miller, ER ;
Norris, K ;
O'Connor, D ;
Ojo, A ;
Phillips, RA ;
Pogue, V ;
Rahman, M ;
Randall, OS ;
Rostand, S ;
Schulman, G ;
Smith, W ;
Thornley-Brown, D ;
Tisher, CC ;
Toto, RD ;
Wright, JT ;
Xu, SC .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (21) :2719-2728
[3]   Prognostic implications of abnormalities in renal function in patients with acute coronary syndromes [J].
Al Suwaidi, J ;
Reddan, DN ;
Williams, K ;
Pieper, KS ;
Harrington, RA ;
Califf, RM ;
Granger, CB ;
Ohman, EM ;
Holmes, DR .
CIRCULATION, 2002, 106 (08) :974-980
[4]   Renal failure predisposes patients to adverse outcome after coronary artery bypass surgery [J].
Anderson, RJ ;
O'Brien, M ;
MaWhinney, S ;
VillaNueva, CB ;
Moritz, TE ;
Sethi, GK ;
Henderson, WG ;
Hammermeister, KE ;
Grover, FL ;
Shroyer, AL .
KIDNEY INTERNATIONAL, 1999, 55 (03) :1057-1062
[5]  
[Anonymous], 2004, DIABETES CARE, DOI DOI 10.2337/DIACARE.27.5.1240-A
[6]  
Arora P, 1999, J AM SOC NEPHROL, V10, P1281
[7]   Effect of calcium channel or beta-blockade on the progression of diabetic nephropathy in African Americans [J].
Bakris, GL ;
Mangrum, A ;
Copley, JB ;
Vicknair, N ;
Sadler, R .
HYPERTENSION, 1997, 29 (03) :744-750
[8]   Calcium channel blockers versus other antihypertensive therapies on progression of NIDDM associated nephropathy [J].
Bakris, GL ;
Copley, JB ;
Vicknair, N ;
Sadler, R ;
Leurgans, S .
KIDNEY INTERNATIONAL, 1996, 50 (05) :1641-1650
[9]   Preserving renal function in adults with hypertension and diabetes: A consensus approach [J].
Bakris, GL ;
Williams, M ;
Dworkin, L ;
Elliott, WJ ;
Epstein, M ;
Toto, R ;
Tuttle, K ;
Douglas, J ;
Hsueh, W ;
Sowers, J .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2000, 36 (03) :646-661
[10]   Overview: End-stage renal disease in the developing world [J].
Barsoum, RS .
ARTIFICIAL ORGANS, 2002, 26 (09) :737-746